Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Lane

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|March 30, 2018
Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA BindingWei-Li Ling, Wai-Heng Lua, Jun-Jie Poh, et al.
Scientific Reports|January 17, 2018
The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-bindingWai-Heng Lua, Wei-Li Ling, Joshua Yi Yeo, et al.
Scientific Reports|July 19, 2018
Author Correction: The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-bindingWai-Heng Lua, Wei-Li Ling, Joshua Yi Yeo, et al.
Frontiers in Oncology|October 5, 2020
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer ModelDiana Spiegelberg, Anja Charlotte Lundgren Mortensen, Kartika Dyah Palupi, et al.
Scientific Reports|December 29, 2022
Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapyXin Yu Koh, Xiao Hui Koh, Diana Spiegelberg, et al.
Oncology Reports|August 8, 2015
Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicityYee-Lin Voon, Munirah Ahmad, Pooi-Fong Wong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|March 30, 2018
Effect of VH-VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA BindingWei-Li Ling, Wai-Heng Lua, Jun-Jie Poh, et al.
Scientific Reports|January 17, 2018
The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-bindingWai-Heng Lua, Wei-Li Ling, Joshua Yi Yeo, et al.
Scientific Reports|July 19, 2018
Author Correction: The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-bindingWai-Heng Lua, Wei-Li Ling, Joshua Yi Yeo, et al.
Frontiers in Oncology|October 5, 2020
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer ModelDiana Spiegelberg, Anja Charlotte Lundgren Mortensen, Kartika Dyah Palupi, et al.
Scientific Reports|December 29, 2022
Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapyXin Yu Koh, Xiao Hui Koh, Diana Spiegelberg, et al.
Oncology Reports|August 8, 2015
Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicityYee-Lin Voon, Munirah Ahmad, Pooi-Fong Wong, et al.
Pageof 2